Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284082 · ClinicalTrials.gov registry record
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 90
- Enrollment target
NCT07284082 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 90 participants.
The verdict
NCT07284082 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
Study Summary
Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of menopause on cardiovascular disease risk factors such as insulin resistance, hypertension, hyperlipidemia, and carotid atherosclerosis using previously collected data. The investigators will look at underlying causes for cardiovascular diseases worsening in menopausal women with HIV by looking at the role of increased inflammation in the body and whether this is altered by weight. The investigators achieve this by enrolling participants who are willing to undergo a whole body MRI.
Interventions
- DIAGNOSTIC_TEST Whole body MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-04-17 |
| Est. Completion | 2030-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07284082
The ClinicalTrials.gov registry entry for NCT07284082 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole body MRI is the first listed.
NCT07284082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07284082 about?
NCT07284082 is a clinical study titled "The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women". Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of menop...
What is the current status of trial NCT07284082?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2026-04-17. Estimated completion is 2030-03-01.
What interventions are being tested in trial NCT07284082?
The interventions under investigation include: Whole body MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07284082?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.